+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay



Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay



Cell Cycle 7(16): 2553-2561



Vascular endothelial growth factor (VEGF) plays a crucial role in angiogenesis and progression of malignant brain tumors. Given the significance of tumor microenvironment in general, and the established role of paracrine VEGF signaling in glioblastoma (GBM) biology in particular, we explored the potential autocrine control of human astrocytoma behavior by VEGF. Using a range of cell and molecular biology approaches to study a panel of astrocytoma (grade III and IV/GBM)-derived cell lines and a series of clinical specimens from low- and high-grade astrocytomas, we show that co-expression of VEGF and VEGF receptors (VEGFRs) occurs commonly in astrocytoma cells. We found VEGF secretion and VEGF-induced biological effects (modulation of cell cycle progression and enhanced viability of glioblastoma cells) to function in an autocrine manner. Morevover, we demonstrated that the autocrine VEGF signaling is mediated via VEGFR2 (KDR), and involves co-activation of the c-Raf/MAPK, PI3K/Akt and PLC/PKC pathways. Blockade of VEGFR2 by the selective inhibitor (SU1498) abrogated the VEGF-mediated enhancement of astrocytoma cell growth and viability under unperturbed culture conditions. In addition, such interference with VEGF-VEGFR2 signaling potentiated the ionizing radiation-induced tumor cell death. In clinical specimens, both VEGFRs and VEGF were co-expressed in astroglial tumor cells, and higher VEGF expression correlated with tumor progression, thereby supporting the relevance of functional VEGF-VEGFR signaling in vivo. Overall, our results are consistent with a potential autocrine role of the VEGF-VEGFR2 (KDR) interplay as a factor contributing to malignant astrocytoma growth and radioresistance, thereby supporting the candidacy of this signaling cascade as a therapeutic target, possibly in combination with radiotherapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051721999

Download citation: RISBibTeXText

PMID: 18719373

DOI: 10.4161/cc.7.16.6442


Related references

Autocrine VEGF-VEGFR2-Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth. Journal of Experimental Medicine 209(3): 507-520, 2012

Angi-11Vegf-C Contributes To Autocrine Vegfr2 Signaling And Affects Cell Viability And Tumor Growth In Glioblastoma. Neuro-Oncology 17(Suppl 5): v43.2-v43, 2015

OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling. Ebiomedicine 2019, 2019

Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Cancer Letters 382(1): 44-52, 2016

Autocrine regulation of cell cycle progression in normal human keratinocytes. In Vitro Cellular & Developmental Biology Animal. 32(10): 640-655, 1996

Direct Autocrine Regulation of Colon Cancer Cell Growth by Vegf Is Mediated via Activation of Vegf-R1/2 and Transactivation of Egf-R: Direct Effect of Vegf on Crc Cell Proliferation and Reduced Apoptosis. Gastroenterology 146(5): S-151, 2014

VEGF-C/Flt-4 axis in tumor cells contributes to the progression of oral squamous cell carcinoma via upregulating VEGF-C itself and contactin-1 in an autocrine manner. American Journal of Cancer Research 8(10): 2046-2063, 2018

Interplay of transcriptional and proteolytic regulation in driving robust cell cycle progression. Molecular Biosystems 8(3): 863-870, 2012

Ginsenoside 20(S)-Protopanaxadiol Suppresses Viability of Human Glioblastoma Cells via Down-regulation of Cell Adhesion Proteins and Cell-cycle Arrest. Anticancer Research 36(3): 925-932, 2016

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy. Molecular Cancer 13: 94, 2015

Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?. Journal of Neuro-Oncology 74(2): 99-103, 2005

Tmod-02Blocking Cxcr4 Increases Survival In A Mouse Model Of Neural Stem Cells-Derived Glioblastoma By Blocking An Autocrine Positive Feedback Loop Regulating Apoptosis And Cell Cycle Progression Via Rb1 And cdk4/cdk6/CyclinD1. Neuro-Oncology 17(Suppl 5): v226.2-v226, 2015

P01.18 * Autocrine Vegfc-Vegfr2 Signaling Is Of Importance For The Growth Of Glioblastoma Multiforme. Neuro-Oncology 16(Suppl 2): ii31, 2014

SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma. Molecular Neurobiology 53(1): 210-215, 2016

Sulfated polysaccharide JCS1S2 inhibits angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Carbohydrate Polymers 207: 502-509, 2019